Jackson Grant Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.93K | Sell |
17
-14
| -45% | -$7.35K | ﹤0.01% | 275 |
|
|
2025
Q1 | $19.7K | Hold |
31
| – | – | 0.01% | 223 |
|
|
2024
Q4 | $22.1K | Hold |
31
| – | – | 0.01% | 222 |
|
|
2024
Q3 | $32.6K | Hold |
31
| – | – | 0.01% | 202 |
|
|
2024
Q2 | $32.6K | Hold |
31
| – | – | 0.01% | 201 |
|
|
2024
Q1 | $29.8K | Hold |
31
| – | – | 0.01% | 206 |
|
|
2023
Q4 | $27.2K | Hold |
31
| – | – | 0.01% | 206 |
|
|
2023
Q3 | $25.5K | Hold |
31
| – | – | 0.01% | 210 |
|
|
2023
Q2 | $22.3K | Hold |
31
| – | – | 0.01% | 220 |
|
|
2023
Q1 | $25.5K | Buy |
31
+3
| +11% | +$2.47K | 0.01% | 240 |
|
|
2022
Q4 | $20.2K | Hold |
28
| – | – | 0.01% | 254 |
|
|
2022
Q3 | $19K | Hold |
28
| – | – | 0.01% | 261 |
|
|
2022
Q2 | $17K | Hold |
28
| – | – | 0.01% | 282 |
|
|
2022
Q1 | $20K | Hold |
28
| – | – | 0.01% | 282 |
|
|
2021
Q4 | $18K | Hold |
28
| – | – | 0.01% | 246 |
|
|
2021
Q3 | $17K | Hold |
28
| – | – | 0.01% | 303 |
|
|
2021
Q2 | $16K | Buy |
28
+4
| +17% | +$2.29K | 0.01% | 321 |
|
|
2021
Q1 | $11K | Buy |
+24
| New | +$11K | 0.01% | 336 |
|